Besides SHR, the novel glucose-related blood biomarkers, such as the fasting blood glucose to estimated average glucose ratio (GAGR) [12], glucose to albumin ratio (GAR) [14], glucose to potassium ratio (GPR) [15], and glucose-triglyceride index (TyG) [16], have been used to assess severity and predict mortality rate in AIS patients. Here, ALB is linked to androgen insensitivity syndrome.